The role of BRCA1 and BRCA2 in prostate cancer
Open Access
- 23 April 2012
- journal article
- review article
- Published by Medknow in Asian Journal of Andrology
- Vol. 14 (3), 409-414
- https://doi.org/10.1038/aja.2011.150
Abstract
AJA publishes new findings in basic and clinical (including modern, traditional and epidemiological) research on Andrology.Keywords
This publication has 110 references indexed in Scilit:
- Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian CancerJAMA, 2011
- BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patientsBritish Journal of Cancer, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibilityNature Genetics, 2009
- Evidence for two independent prostate cancer risk–associated loci in the HNF1B gene at 17q12Nature Genetics, 2008
- Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancersNature, 2008
- Prostate Cancer Susceptibility Loci: Finding the GenesAdvances in experimental medicine and biology, 2008
- The PARP superfamilyBioEssays, 2004
- Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nature Genetics, 1996
- APC mutations occur early during colorectal tumorigenesisNature, 1992